Sanofi may have Dengue vacc by 2015
Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, has begun clinical studies of its investigational tetravalent Dengue vaccine in Singapore and Vietnam. The firm announced it is expanding its global Dengue vaccine program in Asia, where trials are already ongoing in Thailand and the Philippines.
The Bloomberg news service says the trials will recruit 1,200 people in Singapore and 180 in Vietnam. If successful, Sanofi will proceed to final-stage trials, which will involve tens of thousands of people, a spokesperson told Bloomberg. The firm hopes to have a candidate ready to file by 2015.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze